| Organism name | Bacopa monnieri |
|---|---|
| Genus | Bacopa |
| Family | Plantaginaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Bacopa monnieri |
|---|---|
| Linked NCBI taxonomy ID | 263974 |
| Linked level | species |
| Family in NCBI taxonomy | Plantaginaceae |
|---|---|
| ID | 156152 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | asterids |
|---|---|
| ID | 71274 |
| Species | Activity |
|---|---|
| Bacopa monnieri (L.) Pennell | Adaptogen |
| Bacopa monnieri (L.) Pennell | Adaptogenic |
| Bacopa monnieri (L.) Pennell | Analgesic |
| Bacopa monnieri (L.) Pennell | Analgesic |
| Bacopa monnieri (L.) Pennell | Antiamnesic |
| Bacopa monnieri (L.) Pennell | Anticancer |
| Bacopa monnieri (L.) Pennell | Anticancer |
| Bacopa monnieri (L.) Pennell | Anticonvulsant |
| Bacopa monnieri (L.) Pennell | Anticonvulsant |
| Bacopa monnieri (L.) Pennell | Antidepressant |
| Bacopa monnieri (L.) Pennell | Antidote |
| Bacopa monnieri (L.) Pennell | Antiedemic |
| Bacopa monnieri (L.) Pennell | Antifatigue |
| Bacopa monnieri (L.) Pennell | Antiinflammatory |
| Bacopa monnieri (L.) Pennell | Antiinflammatory |
| Bacopa monnieri (L.) Pennell | Antileishmanic |
| Bacopa monnieri (L.) Pennell | Antioxidant |
| Bacopa monnieri (L.) Pennell | Antioxidant |
| Bacopa monnieri (L.) Pennell | Antiparalytic |
| Bacopa monnieri (L.) Pennell | Antiprostaglandin-E2 |
| Bacopa monnieri (L.) Pennell | Antispasmodic |
| Bacopa monnieri (L.) Pennell | Antistress |
| Bacopa monnieri (L.) Pennell | Antitumor |
| Bacopa monnieri (L.) Pennell | Antitumor |
| Bacopa monnieri (L.) Pennell | Antiulcer |
| Bacopa monnieri (L.) Pennell | Anxiolytic |
| Bacopa monnieri (L.) Pennell | Anxiolytic |
| Bacopa monnieri (L.) Pennell | Aperient |
| Bacopa monnieri (L.) Pennell | Aperient |
| Bacopa monnieri (L.) Pennell | Aphrodisiac |
| Bacopa monnieri (L.) Pennell | Aphrodisiac |
| Bacopa monnieri (L.) Pennell | Bactericide |
| Bacopa monnieri (L.) Pennell | Broncho-Vasodilator |
| Bacopa monnieri (L.) Pennell | Calcium-Antagonist |
| Bacopa monnieri (L.) Pennell | Cardiotonic |
| Bacopa monnieri (L.) Pennell | Cardiotonic |
| Bacopa monnieri (L.) Pennell | Cerebrotonic |
| Bacopa monnieri (L.) Pennell | Cerebrotonic |
| Bacopa monnieri (L.) Pennell | Convulsant |
| Bacopa monnieri (L.) Pennell | Convulsant |
| Bacopa monnieri (L.) Pennell | Diuretic |
| Bacopa monnieri (L.) Pennell | Diuretic |
| Bacopa monnieri (L.) Pennell | Emetic |
| Bacopa monnieri (L.) Pennell | Emetic |
| Bacopa monnieri (L.) Pennell | Enterotonic |
| Bacopa monnieri (L.) Pennell | Expectorant |
| Bacopa monnieri (L.) Pennell | Expectorant |
| Bacopa monnieri (L.) Pennell | Febrifuge |
| Bacopa monnieri (L.) Pennell | Fungicide |
| Bacopa monnieri (L.) Pennell | GABA-nergic |
| Bacopa monnieri (L.) Pennell | Gastroprotective |
| Bacopa monnieri (L.) Pennell | Glutaminergic |
| Bacopa monnieri (L.) Pennell | Hepatoprotective |
| Bacopa monnieri (L.) Pennell | Herbicide |
| Bacopa monnieri (L.) Pennell | Hydragogue |
| Bacopa monnieri (L.) Pennell | Hypertensive |
| Bacopa monnieri (L.) Pennell | Hypertensive |
| Bacopa monnieri (L.) Pennell | Hypotensive |
| Bacopa monnieri (L.) Pennell | Hypotensive |
| Bacopa monnieri (L.) Pennell | Laxative |
| Bacopa monnieri (L.) Pennell | Memorigenic |
| Bacopa monnieri (L.) Pennell | Memorigenic |
| Bacopa monnieri (L.) Pennell | Myorelaxant |
| Bacopa monnieri (L.) Pennell | Negative Chronotropic |
| Bacopa monnieri (L.) Pennell | Negative-Chronotropic |
| Bacopa monnieri (L.) Pennell | Nervine |
| Bacopa monnieri (L.) Pennell | Nervine |
| Bacopa monnieri (L.) Pennell | Neuroprotective |
| Bacopa monnieri (L.) Pennell | Neurotonic |
| Bacopa monnieri (L.) Pennell | Neurotonic |
| Bacopa monnieri (L.) Pennell | Nootropic |
| Bacopa monnieri (L.) Pennell | Purgative |
| Bacopa monnieri (L.) Pennell | Respiratonic |
| Bacopa monnieri (L.) Pennell | Rubefacient |
| Bacopa monnieri (L.) Pennell | Sedative |
| Bacopa monnieri (L.) Pennell | Sedative |
| Bacopa monnieri (L.) Pennell | Spasmogenic |
| Bacopa monnieri (L.) Pennell | Spasmogenic |
| Bacopa monnieri (L.) Pennell | Tonic |
| Bacopa monnieri (L.) Pennell | Tonic |
| Bacopa monnieri (L.) Pennell | toxic |
| Bacopa monnieri (L.) Pennell | Tracheorelaxant |
| Bacopa monnieri (L.) Pennell | Tranquilizer |
| Bacopa monnieri (L.) Pennell | Tranquilizer |
| Bacopa monnieri (L.) Pennell | Vasoconstrictor |
| Bacopa monnieri (L.) Pennell | Vasoconstrictor |
| Bacopa monnieri (L.) Pennell | Vasodilator |
| Bacopa monnieri (L.) Pennell | Vermifuge |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00029785
|
Bacosine
|
No. 23 | No. 51 |
|
||||
|
C00029775
|
Bacopaside II
|
No. 32 | No. 51 |
|
||||
|
C00029768
|
Bacopasaponin B
|
No. 32 | No. 51 |
|
||||
|
C00029769
|
Bacopasaponin C
|
CHEMBL225246
|
No. 32 | No. 51 |
|
|||
|
C00029770
|
Bacopasaponin D
|
No. 32 | No. 51 |
|
||||
|
C00029771
|
Bacopasaponin E
|
No. 32 | No. 51 |
|
||||
|
C00029772
|
Bacopasaponin F
/ Bacopaside VIII |
No. 32 | No. 51 |
|
||||
|
C00029773
|
Bacopasaponin G
|
No. 32 | No. 51 |
|
||||
|
C00029774
|
Bacopaside I
|
CHEMBL390537
|
No. 32 | No. 51 |
|
|||
|
C00029767
|
Bacopasaponin A
|
No. 32 | No. 51 |
|
||||
|
C00029776
|
Bacopaside III
/ (-)-Bacopaside III |
No. 32 | No. 51 |
|
||||
|
C00029777
|
Bacopaside IV
|
No. 32 | No. 51 |
|
||||
|
C00029778
|
Bacopaside N1
|
No. 32 | No. 51 |
|
||||
|
C00029779
|
Bacopaside N2
|
No. 32 | No. 51 |
|
||||
|
C00038575
|
Bacopaside VI
/ (-)-Bacopaside VI |
No. 32 | No. 51 |
|
||||
|
C00029781
|
Bacopaside X
|
CHEMBL225246
|
No. 32 | No. 51 |
|
|||
|
C00029782
|
Bacoside A1
|
No. 32 | No. 51 |
|
||||
|
C00029783
|
Bacoside A2
|
No. 32 | No. 51 |
|
||||
|
C00029784
|
Bacoside A3
|
CHEMBL447375
|
C087625
|
No. 32 | No. 51 |
|
||
|
C00029780
|
Bacopaside V
|
No. 32 | No. 51 |
|
||||
|
C00003686
|
Cucurbitacin E
|
CHEMBL455056
|
C102326
|
3 / 1 / 2 | No. 220 | No. 11 |
|
|
|
C00034445
|
Bacobitacin A
/ (-)-Bacobitacin A |
No. 220 | No. 11 |
|
||||
|
C00034446
|
Bacobitacin B
/ (-)-Bacobitacin B |
No. 220 | No. 11 |
|
||||
|
C00029786
|
Bacosterol-3-O-beta-D-glucopyranoside
|
No. 520 |
|
|||||
|
C00034608
|
Monnieraside III
/ (-)-Monnieraside III |
No. 532 |
|
|||||
|
C00034607
|
Monnieraside I
/ (-)-Monnieraside I |
No. 532 |
|
|||||
|
C00034447
|
Bacobitacin C
/ (-)-Bacobitacin C |
No. 4491 |
|
|||||
|
C00034448
|
Bacobitacin D
/ (-)-Bacobitacin D |
No. 4491 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P20701 | Integrin alpha-L | Membrane receptor | C00003686 | 0 / 0 |
| P23528 | Cofilin-1 | Unclassified protein | C00003686 | 0 / 0 |
| P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00003686 | 1 / 2 |